Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

ATG001

Sigma-Aldrich

Raji CD19 Antigen Panel Cell Lines

human lymph (lymphoblast), lymphoblast

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Code UNSPSC :
41106514
Nomenclature NACRES :
NA.41

product name

Raji CD19 Antigen Panel Cell Lines,

Source biologique

human lymph (lymphoblast)

Mode de croissance

suspension

Morphologie

lymphoblast

Conditions d'expédition

dry ice

Température de stockage

−196°C

Description générale

This product is a panel of three (3) genetically modified cell lines involving the CD19 gene. The panel consists of a CD19 knockout cell line (CD19-/-) as well as a CD19low and a CD19high expression cell line. The CD19-/- cell line was generated using CompoZr® Zinc Finger Nuclease technology, and the two CD19 expression cell lines were generated using MISSION® lentivirus. The CD19low and CD19high cell lines express CD19 at low and high levels relative to the CD19-/- cell line (CD19high > CD19low > CD19-/-) as measured via fluorescence-activated cell sorting (FACS). As a comparison, wild type Raji cells demonstrate CD19medium expression as measured via FACS.

The STR profile of these cell lines match that of its parental cell line - ECACC catalog number 85011429.

Description de la lignée cellulaire

Established in 1963 from Burkitt′s lymphoma in an 11 year old male. Growth is in the form of single cells without attachment and as macroscopically visible clumps containing many hundreds of cells. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. Raji is sometimes referred to as a ′non-producer′; the EBV genome carries deletions attributed to preventing the formation of virus particles. Ethnicity: Black

Caractéristiques et avantages

The Raji CD19 antigen panel cell lines feature CD19 expressed at varying levels (KO, low, and high). These cell lines enable researchers to screen and evaluate the binding and potency of CD19-targeted immunotherapies in a biologically-relevant cellular research model.

Composants

ATG001A-1VL: Raji CD19 Knockout
ATG001B-1VL: Raji CD19 Low
ATG001C-1VL: Raji CD19 High

Qualité

Tested for Mycoplasma, bacterial and fungal content, post-freeze viability, and short terminal repeat (STR) analysis for cell line identification.

Informations légales

CompoZr is a registered trademark of Merck KGaA, Darmstadt, Germany
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Code de la classe de stockage

10 - Combustible liquids


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique